Insider · CIK 0001694934
Michael J. Purcell
Files at HEPA (Hepion Pharmaceuticals, Inc.), TRHC (Tabula Rasa HealthCare, Inc.), IMXI (International Money Express, Inc.). First filing Apr 27, 2026, latest Aug 12, 2026.
In brief
Michael J. Purcell files SEC Form 4 as director at HEPA (Hepion Pharmaceuticals, Inc.), and also at TRHC (Tabula Rasa HealthCare, Inc.), IMXI (International Money Express, Inc.). Since Apr 27, 2026, Michael J. Purcell has reported 2 open-market buys worth $150k and 0 open-market sells worth $0, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Michael J. Purcell has 0, so none is measured yet.
The newest scored trade: bought $100k of HEPA on Aug 3, 2026, filed Aug 12, 2026, scored 54 (moderate). In the last 12 months: 2 buys worth $150k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HEPA: Hepion Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | Hepion Pharmaceuticals, Inc. | $100k 2,000,000 shares | +160% | +106% from low-24% from high | |
| 53Moderate | Hepion Pharmaceuticals, Inc. | $50k 1,250,000 shares | - | +14% from low-90% from high |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,360 | $11.49 | $16k | 99,918 | 11 d ago |
| Aug 19, 2026 | HEPA Hepion Pharmaceuticals, Inc. | AGrant or award Stock Optionsderivative | +299,000 | $0.00 | $0 | 299,000 | 33 d ago |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,000,000 | $0.05 | $100k | 3,250,000 | Aug 12, 2026 |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Warrantsderivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Aug 12, 2026 |
| Jul 16, 2026 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +10,862 | $13.81 | $150k | 98,558 | Jul 20, 2026 |
| Jul 1, 2026 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,075 | $14.54 | $16k | 87,696 | Jul 2, 2026 |
| Apr 21, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +1,250,000 | $0.04 | $50k | 1,250,000 | Apr 27, 2026 |
| Apr 1, 2026 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +989 | $15.80 | $16k | 86,621 | Apr 2, 2026 |
| Jan 1, 2026 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,019 | $15.34 | $16k | 85,632 | Jan 5, 2026 |
| Oct 1, 2025 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,122 | $13.93 | $16k | 84,613 | Oct 2, 2025 |
| Jul 1, 2025 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,482 | $10.54 | $16k | 83,491 | Jul 3, 2025 |
| Jun 20, 2025 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +14,867 | $10.09 | $150k | 82,009 | Jun 24, 2025 |
| Apr 1, 2025 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +1,223 | $12.78 | $16k | 67,142 | Apr 3, 2025 |
| Jan 1, 2025 | IMXI International Money Express, Inc. | AGrant or award Common Stock | +750 | $20.83 | $16k | 65,919 | Jan 3, 2025 |
| Nov 3, 2023 | TRHC Tabula Rasa HealthCare, Inc. | DDisposition to issuer Common Stock | -88,514 | - | - | 50,808 | Nov 14, 2023 |
| Nov 3, 2023 | TRHC Tabula Rasa HealthCare, Inc. | DDisposition to issuer Common Stock | -50,808 | - | - | 0 | Nov 14, 2023 |
Questions about Michael J. Purcell
Answered from the filings on this page, as of the latest one.
Is Michael J. Purcell buying or selling?
In the last 12 months Michael J. Purcell reported 2 open-market buys worth $150k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of HEPA on Aug 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael J. Purcell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael J. Purcell has 0.
Where does Michael J. Purcell file Form 4?
Michael J. Purcell has filed Form 4 at HEPA (Hepion Pharmaceuticals, Inc.); TRHC (Tabula Rasa HealthCare, Inc.); IMXI (International Money Express, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.